Literature DB >> 9499063

Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin.

M H Skiadopoulos1, A A McBride.   

Abstract

The bovine papillomavirus type 1 E2 transactivator protein is required for viral transcriptional regulation and DNA replication and may be important for long-term episomal maintenance of viral genomes within replicating cells (M. Piirsoo, E. Ustav, T. Mandel, A. Stenlund, and M. Ustav, EMBO J. 15:1-11, 1996). We have evidence that, in contrast to most other transcriptional transactivators, the E2 transactivator protein is associated with mitotic chromosomes in dividing cells. The shorter E2-TR and E8/E2 repressor proteins do not bind to mitotic chromatin, and the N-terminal transactivation domain of the E2 protein is necessary for the association. However, the DNA binding function of E2 is not required. We have found that bovine papillomavirus type 1 genomes are also associated with mitotic chromosomes, and we propose a model in which E2-bound viral genomes are transiently associated with cellular chromosomes during mitosis to ensure that viral genomes are segregated to daughter cells in approximately equal numbers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499063      PMCID: PMC109502          DOI: 10.1128/JVI.72.3.2079-2088.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target.

Authors:  R S Hegde; S R Grossman; L A Laimins; P B Sigler
Journal:  Nature       Date:  1992-10-08       Impact factor: 49.962

Review 2.  The potential of extrachromosomal replicating vectors for gene therapy.

Authors:  M P Calos
Journal:  Trends Genet       Date:  1996-11       Impact factor: 11.639

Review 3.  The chromosome periphery during mitosis.

Authors:  D Hernandez-Verdun; T Gautier
Journal:  Bioessays       Date:  1994-03       Impact factor: 4.345

4.  Binding of bovine papillomavirus E1 to the origin is not sufficient for DNA replication.

Authors:  B A Spalholz; A A McBride; T Sarafi; J Quintero
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

5.  The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase.

Authors:  L Yang; I Mohr; E Fouts; D A Lim; M Nohaile; M Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

6.  The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication.

Authors:  R Li; M R Botchan
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

7.  Segregation properties of bovine papillomaviral plasmid DNA.

Authors:  A C Stewart; N Jareborg; M Simonsson; A Alderborn; S Burnett
Journal:  J Mol Biol       Date:  1994-02-18       Impact factor: 5.469

8.  E1 protein of human papillomavirus is a DNA helicase/ATPase.

Authors:  F J Hughes; M A Romanos
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

9.  Interaction with the nuclear matrix of a chimeric construct containing a replication origin and a transcription unit.

Authors:  J N Adom; F Gouilleux; H Richard-Foy
Journal:  Biochim Biophys Acta       Date:  1992-12-29

10.  Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin.

Authors:  Y S Seo; F Müller; M Lusky; E Gibbs; H Y Kim; B Phillips; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

View more
  86 in total

Review 1.  Mechanisms of human papillomavirus-induced oncogenesis.

Authors:  Karl Münger; Amy Baldwin; Kirsten M Edwards; Hiroyuki Hayakawa; Christine L Nguyen; Michael Owens; Miranda Grace; Kyungwon Huh
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression.

Authors:  Jasmin Fertey; Ingo Ammermann; Michael Winkler; Reinhard Stöger; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

Review 3.  Hitchhiking on host chromatin: how papillomaviruses persist.

Authors:  Alison A McBride; Nozomi Sakakibara; Wesley H Stepp; Moon Kyoo Jang
Journal:  Biochim Biophys Acta       Date:  2012-01-28

4.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.

Authors:  Jianxin You; Viswanathan Srinivasan; Gerald V Denis; William J Harrington; Mary E Ballestas; Kenneth M Kaye; Peter M Howley
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells.

Authors:  Jianxin You; Michal-Ruth Schweiger; Peter M Howley
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin.

Authors:  Maria G McPhillips; Keiko Ozato; Alison A McBride
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Association of bovine papillomavirus E2 protein with nuclear structures in vivo.

Authors:  Reet Kurg; Kristiina Sild; Aigi Ilves; Mari Sepp; Mart Ustav
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.

Authors:  Michal-Ruth Schweiger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

9.  Brd4 links chromatin targeting to HPV transcriptional silencing.

Authors:  Shwu-Yuan Wu; A-Young Lee; Samuel Y Hou; Jongsook Kim Kemper; Hediye Erdjument-Bromage; Paul Tempst; Cheng-Ming Chiang
Journal:  Genes Dev       Date:  2006-08-18       Impact factor: 11.361

Review 10.  Mechanisms of persistence by small DNA tumor viruses.

Authors:  Nathan A Krump; Wei Liu; Jianxin You
Journal:  Curr Opin Virol       Date:  2018-10-01       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.